Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,111 | -30,247 | -16,222 | -1,619 | -24,414 |
| Depreciation Amortization | 45 | 33 | 22 | 53 | 198 |
| Accounts receivable | N/A | N/A | N/A | -738 | -311 |
| Accounts payable and accrued liabilities | 3,171 | 2,292 | 1,867 | 924 | 263 |
| Other Working Capital | 2,126 | -127 | -1,309 | -731 | -2,192 |
| Other Operating Activity | 13,967 | 11,243 | 9,123 | 3,209 | -1,110 |
| Operating Cash Flow | $-26,802 | $-16,806 | $-6,519 | $1,098 | $-27,566 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47 | -47 | -61 | -47 | 4,310 |
| Investing Cash Flow | $-47 | $-47 | $-61 | $-47 | $4,310 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -3,055 |
| Common Stock Issued | 94,150 | 94,139 | 94,149 | 94,150 | 48,508 |
| Other Financing Activity | 45,032 | 45,032 | 44,780 | 44,525 | 385 |
| Financing Cash Flow | $139,182 | $139,171 | $138,929 | $138,675 | $45,838 |
| Exchange Rate Effect | -1,679 | -1,947 | -2,352 | -41 | 718 |
| Beginning Cash Position | 53,231 | 53,231 | 53,231 | 53,231 | 29,931 |
| End Cash Position | 163,885 | 173,602 | 183,228 | 192,916 | 53,231 |
| Net Cash Flow | $110,654 | $120,371 | $129,997 | $139,685 | $23,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,802 | -16,806 | -6,519 | 1,098 | -27,566 |
| Capital Expenditure | -61 | -61 | -61 | -47 | -190 |
| Free Cash Flow | -26,863 | -16,867 | -6,580 | 1,051 | -27,756 |